Fatty Alcohol Synthesis and Virulence in Leishmania
利什曼原虫的脂肪醇合成和毒力
基本信息
- 批准号:8853768
- 负责人:
- 金额:$ 12.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AnabolismAnimal DiseasesAntibodiesBiochemistryBiogenesisBiological AssayBiologyBiomedical ResearchCell physiologyCell surfaceCellular biologyClinical ResearchClinical TrialsComplementDataDevelopmentDrug DesignEnvironmentEnzymesEstersEthersFatty AcidsFatty AlcoholsGPI Membrane AnchorsGenerationsGeneticGlycerolGoalsGrowthHumanImmunofluorescence ImmunologicIn VitroInfectionInterventionKnowledgeLaboratoriesLeadLearningLeishmaniaLeishmaniasisLife Cycle StagesLipid BiochemistryLipidsMastigophoraMembraneMetabolicMiltefosineMolecular BiologyMusOrthologous GeneParasitesParasitic DiseasesPathogenesisPathway interactionsPeptide HydrolasesPharmaceutical PreparationsPhospholipid EthersPlayPositioning AttributeProcessProductionPropertyPublic HealthResearchRoleRouteSand FliesStructureStudentsTechniquesTestingUniversitiesVertebral columnVirulenceVirulence FactorsYeastsbasefightingglycerone-phosphate O-acyltransferasehexadecanal dehydrogenase (acylating)human diseasein vivointerdisciplinary approachlipid biosynthesislipid metabolismlipophosphonoglycanmacrophagemutantnovelnovel strategiespathogenpreventpublic health relevancevector
项目摘要
DESCRIPTION (provided by applicant): Leishmania species are protozoan parasites that cause important human diseases in the tropics and subtropics worldwide and, thus, represent a major public health problem. Ether lipids are important constituents of Leishmania membranes, and more importantly, are structural components of various virulence factors, such as the very abundant cell surface lipophosphoglycan and the glycosylphosphatidylinositol(GPI)-anchored protease GP63. Both play crucial roles during the entire life cycle of the parasite. Ether lipid-based drugs such as miltefosine, currently used in clinical trials, inhibit parasite growth in vitr and in vivo, and are likely to interfere with the ether lipid biosynthetic pathway. This supports te idea that this metabolic route can be targeted for further drug design. Our previous studies have established that the first two enzymes of the ether lipid biosynthetic pathway in L. major, dihydroxyacetonephosphate acyltransferase LmDAT and alkyl dihydroxyacetonephosphate synthase LmADS, are implicated in the synthesis of the virulence factor lipophosphoglycan and cellular ether lipids, which play a crucial role in parasite pathogenesis. Our preliminary results have suggested that i) LmFAR is involved in the production of fatty alcohols which are essential for the synthesis of ether lipids, and ii) LmFAR is important for growth of the parasite. This proposal will test the central hypothesis that Leishmania peroxisomal fatty acyl-CoA reductase LmFAR is essential for ether lipid metabolism and generation of the virulence factor lipophosphoglycan, and consequently, for pathogenesis. To test this hypothesis, we propose to use two Specific Aims that combine a multidisciplinary approach that involves molecular biology, genetics, biochemistry, and cell biology techniques. In Specific Aim 1, we will investigate the enzymatic properties of LmFAR and its subcellular localization. In Specific Aim 2, we will assess the importance of LmFAR in ether lipid biosynthesis, virulence, and sensitivity to ether lipid-based drugs. Understanding the function of LmFAR is important for the development of novel strategies to prevent and treat Leishmania infections. In addition, this project will enhance the research environment at St. John's University by providing underprivileged students with numerous opportunities to learn the fundamentals of biomedical research.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RACHEL ZUFFEREY其他文献
RACHEL ZUFFEREY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RACHEL ZUFFEREY', 18)}}的其他基金
Fatty Alcohol Synthesis and Virulence in Leishmania
利什曼原虫的脂肪醇合成和毒力
- 批准号:
9244051 - 财政年份:2015
- 资助金额:
$ 12.38万 - 项目类别:
Phosphatidylcholine biosynthesis and miltefosine mode of action in Leishmania
利什曼原虫中磷脂酰胆碱的生物合成和米替福辛的作用模式
- 批准号:
7450607 - 财政年份:2009
- 资助金额:
$ 12.38万 - 项目类别:
PHOSPHATIDYLCHOLINE BIOSYNTHESIS AND ANTICANCER AGENT MILTEFOSINE
磷脂酰胆碱生物合成和抗癌剂米替福辛
- 批准号:
7959405 - 财政年份:2009
- 资助金额:
$ 12.38万 - 项目类别:
Phosphatidylcholine biosynthesis and miltefosine mode of action in Leishmania
利什曼原虫中磷脂酰胆碱的生物合成和米替福辛的作用模式
- 批准号:
7843513 - 财政年份:2009
- 资助金额:
$ 12.38万 - 项目类别:
相似海外基金
SPIDVAC - Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot-and-mouth disease
SPIDVAC - 改善重点动物疾病的控制:针对非洲马病、小反刍兽疫和口蹄疫的新型疫苗和伴随诊断测试
- 批准号:
10043719 - 财政年份:2022
- 资助金额:
$ 12.38万 - 项目类别:
EU-Funded
Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot- and-mouth disease
改善重点动物疾病的控制:针对非洲马病、小反刍兽疫和口蹄疫的新型疫苗和伴随诊断测试
- 批准号:
10059336 - 财政年份:2022
- 资助金额:
$ 12.38万 - 项目类别:
EU-Funded
Generation of transboundary animal diseases-resistant animals by genetic modification technologies to Rab-GTPases genes
利用Rab-GTP酶基因转基因技术培育跨境动物抗病动物
- 批准号:
20K20577 - 财政年份:2020
- 资助金额:
$ 12.38万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Transmission: Astonishing Tales of Human-Animal Diseases
传播:人畜疾病的惊人故事
- 批准号:
9096618 - 财政年份:2016
- 资助金额:
$ 12.38万 - 项目类别:
13 Development of magnetometer immunoassay technology for the rapid and cost effective detection of endemic animal diseases and pathogens (zoonoses)
13 开发磁力计免疫测定技术,用于快速且经济有效地检测地方性动物疾病和病原体(人畜共患病)
- 批准号:
BB/L011360/1 - 财政年份:2013
- 资助金额:
$ 12.38万 - 项目类别:
Research Grant
Application of a lipocalin towards a biomarker for livestock animal diseases
脂质运载蛋白在畜牧动物疾病生物标志物中的应用
- 批准号:
25660216 - 财政年份:2013
- 资助金额:
$ 12.38万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of magnetometer immunoassay (MIA) technology for the rapid and cost effective detection of endemic animal diseases and pathogens (zoonoses) in a decentralised, point of use, setting
开发磁力计免疫分析 (MIA) 技术,用于在分散的使用点环境中快速且经济高效地检测地方性动物疾病和病原体(人畜共患病)
- 批准号:
101466 - 财政年份:2013
- 资助金额:
$ 12.38万 - 项目类别:
Collaborative R&D
Establishment of genetic engineering method for Pasteurellaceae bacteria from animal diseases.
动物疫病巴氏杆菌基因工程方法的建立
- 批准号:
22580359 - 财政年份:2010
- 资助金额:
$ 12.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Practical control of pathogens which cases stock animal diseases
畜牧动物疾病病原体的实际控制
- 批准号:
21360399 - 财政年份:2009
- 资助金额:
$ 12.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Environmental evaluation, practical use of the resources and investigation of the domestic animal diseases using the living body information of small antelopes in Africa
利用非洲小羚羊活体信息进行环境评价、资源实用化及家畜疾病调查
- 批准号:
21255010 - 财政年份:2009
- 资助金额:
$ 12.38万 - 项目类别:
Grant-in-Aid for Scientific Research (A)